Company Filing History:
2 out of 59 
2 out of 15 
2 out of 5 
Years Active: 2013-2014
Title: The Innovations of Tadashi Okawara
Introduction
Tadashi Okawara is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential anticancer properties. With a total of two patents to his name, Okawara's work reflects a commitment to advancing medical science.
Latest Patents
One of Okawara's latest patents is a 1,3,4-oxadiazole-2-carboxamide compound. This compound exhibits STAT3 inhibitory activity, making it useful as an anticancer agent. The patent details a compound represented by a specific formula, where Ar represents a furyl group, and R can be a hydrogen atom or similar. Another significant patent involves a STAT3 inhibitor that contains a quinolinecarboxamide derivative as its active ingredient. This invention also includes a detailed formula, indicating various chemical components that contribute to its efficacy.
Career Highlights
Throughout his career, Okawara has worked with reputable organizations such as Pharmadesign, Inc. and Shizuoka Prefecture. His experience in these companies has allowed him to refine his skills and contribute to innovative projects in the pharmaceutical industry.
Collaborations
Okawara has collaborated with notable colleagues, including Akira Asai and Kenji Matsuno. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Tadashi Okawara's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving cancer treatment options. His work continues to inspire advancements in medical research and development.